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ABSTRACT 
The first phytochemical investigation of the leaf and branch extracts of Garcinia 
mckeaniana has led to the isolation and characterization of five new polyoxygenated and 
prenylated xanthones, mckeanianones A-E (1-5), and one new biflavone, mckeaniabiflavone 
(6), together with thirteen known compounds (7-19). The diprenylated pyrano-xanthones (1-
3) and the biflavone (6) were isolated from the leaves while the monoprenylated xanthones (4 
and 5) were isolated from the branches. The structures of all isolated compounds were 
elucidated based on spectroscopic methods and were evaluated for their antimalarial activities 
against the Plasmodium falciparum strains, TM4 and K1 (a multidrug resistant strain), and 
cytotoxicity against a Vero cell line (African green monkey kidney cells). The pyrano-
xanthones (1-3, 7 and 8), having two isoprene units, were generally the most active 
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compounds with IC50 values in the range of 6.0±1.1 
_ 8.5±1.2 and 3.6±1.7 _ 7.3±1.2 µM, 
respectively against the TM4 and K1 strains. Of these compounds 2, 3 and 8 were 2-5 times 
less cytotoxic against a Vero cell line (IC50 values of 12.6±0.9, 29.5±3.9 and 13.2±4.6 µM, 
respectively) in comparison with their antiplasmodial activities. 
Keywords: Garcinia mckeniana, Clausiaceae, pyrano-xanthone, antimalarial activity 
 
1. Introduction 
Garcinia plants (Clusiaceae) are well documented for producing a variety of secondary 
metabolites, especially xanthones,1a-d flavonoids,1d benzophenones2 and terpenoids.1a These 
plants have been used in traditional medicines1d,3a-c and some of the compounds isolated from 
these plants have shown noteworthy pharmaceutical activities, including antimalarial,4 
antimicrobial,5a-c antioxidant5c and cytotoxic activities.6 Thus Garcinia plants are an 
outstanding source of bioactive phytochemicals and therefore an important species to 
investigate for new bioactive compounds. In our continuous research for new bioactive 
metabolites from Garcinia plants,5a-b,7a-b we herein report our results from the first 
phytochemical investigation of the leaf and branch extracts from Garcinia mckeaniana Craib. 
This plant is locally named “Ma da” and is found in the North of Thailand. This study 
resulted in the isolation of six new natural products (1-6), together with thirteen known 
compounds (7-19). The biological activities of these compounds against the Plasmodium 
falciparum strains, TM4 and K1 (a multidrug resistant strain) and their cytotoxicities against 
a Vero cell line are reported. 
 
2. Results and discussion 
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The concentrated acetone extract of the air dried leaves of G. mckeaniana was 
subjected to column chromatography and afforded three new xanthones, mckeanianones A-C 
(1-3), and one new biflavone, mckeaniabiflavone (6), together with three known compounds, 
bannaxanthones I (7)8 and E (8),6 and amentoflavone (9).9 The crude acetone extract of the air 
dried branches of G. mckeaniana was separated by column chromatography resulting in the 
isolation of two new natural xanthones, mckeanianones D-E (4-5) along with ten known 
compounds, pancixanthones A and B (10 and 17),10 neriifolone A (11),11 1,3,5-trihydroxy-2-
(3-methylbut-2-enyl)-9H-xanthen-9-one (12),12 1,3,6-trihydroxy-7-methoxyxanthone (13),13 
1,3,5-trihydroxyxanthone (14),14 buchanaxanthone (15),15 5-O-methyl-2-
deprenylrheediaxanthone B (16),16 assiguxanthone A (18)17 and 1,3,7-trihydroxy-2-(3-
methylbut-2-enyl)-xanthone (19)18 (Fig. 1). Full experimental information is provided in the 
Supplementary data. 
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Fig. 1. Structures of compounds 1-19 
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Mckeanianone A (1) was obtained as a yellow solid (mp 187-189 °C), whose molecular 
formula was determined to be C28H30O7 from the positive ion HRESI-TOFMS [found m/z 
479.2063 (calcd for 479.2070) [M+H]+]. The UV spectrum displayed absorption bands at 
max (MeOH) 217, 295, 337 and 384 nm, suggesting the presence of a xanthone 
chromophore.19 The IR spectrum showed hydroxy and xanthone carbonyl functional group 
stretching bands at 3418 and 1649 cm-1, respectively. The 1H NMR spectrum (Table 1) 
displayed resonances for a chelated hydroxy proton at H 13.97 (1H, s), a dimethylchromene 
unit [H  6.69 (1H, d, J = 10.0 Hz, H-11), 5.69 (1H, d, J = 10.0 Hz, H-12) and 1.47 (6H, s, H-
14, H-15)] and two sets of prenyl units [H  5.31 (1H, brt, J = 6.2 Hz, H-22), 4.17 (2H, d, J = 
6.2 Hz, H-21), 1.86 (3H, s, H-25) and 1.64 (3H, s, H-24); and 5.21 (1H, brt, J = 6.8, H-17), 
3.42 (2H, d, J = 6.8 Hz, H-16), 1.83 (3H, s, H-20) and 1.63 (3H, s, H-19)]. The HMBC 
correlations between the 1-OH resonance (H 13.97) and those of C-1 (C 156.7) and C-9a (C 
104.1) confirmed that the chelated hydroxy group (H 13.97) was attached at C-1. The 
dimethylchromene ring was located at C-2 (C 104.7) and an ether linkage at C-3 (C 157.7) 
on the basis of the HMBC correlations of the lowerfield olefinic proton resonance at H 6.69 
(corresponding to H-11) to C-2 and C-3. One of the prenyl units (H 5.21, 3.42, 1.83 and 
1.63) was assigned to position C-4 (C 106.9), according to the HMBC correlations of the 
methylene protons, H-16 (H 3.42), of this prenyl unit with C-3, C-4 and C-4a (C 154.3). The 
other prenyl unit was located at C-8 (C 129.0) as suggested from the HMBC correlations 
between the methylene protons, H-21 (H 4.17) with the oxygenated carbons C-7 (C 141.8), 
C-8 and C-8a (C 111.8). The substituents at C-5 (C 152.5) and C-6 (C 152.6) were assigned 
as hydroxy groups on the basis of their chemical shifts. These correlations established 
mckeanianone A as 1,5,6,7-tetrahydroxy-6,6-dimethyl-2H-pyrano(2,3:3,2)-4,8-di(3-
methylbut-2-enyl)-xanthone (1). 
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Mckeanianone B (2) was obtained as a yellow viscous oil and the molecular formula, 
C28H30O8, was determined by HRESI-TOFMS [found m/z 517.1839 (calcd for 517.1838) 
[M+Na]+]. A careful analysis of its UV and IR spectra showed absorption bands similar to 
those of compound 1. Furthermore, the 1H NMR spectrum (Table 1) displayed resonances for 
a chelated hydroxy proton (H 13.78, brs), a dimethylchromene ring [H 6.69 (1H, d, J = 10.0 
Hz, H-11), 5.54 (1H, d, J = 10.0 Hz, H-12) and 1.44 (6H, s, H-14, H-15)], one single 
aromatic proton (H 6.25, H-4) and the two sets of oxygenated prenyl units [H 5.40 (1H, t, J 
= 8.0 Hz, H-17), 4.30 (2H, s, H-20), 3.60 (2H, d, J = 8.0 Hz, H-16), 1.73 (3H, s, H-19) and 
5.59 (1H, t, J = 7.8 Hz, H-22), 4.26 (2H, s, H-25), 4.13 (2H, d, J = 7.8 Hz, H-21) and 1.73 
(3H, s, H-24)]. 2D-NMR Data ananlysis of compound 2 suggested the same pyrano-xanthone 
structure as compound 1 with the chelated hydroxy proton attached at C-1 (C 157.7) and the 
dimethylchromene ring fused to C-2 (C 104.3) and C-3 (C 159.7). In addition, the aromatic 
proton resonating at H 6.25 was assigned to H-4 due to its HMBC correlations with the 13C 
NMR resonances for C-2, C-3, C-4a (C 156.3) and C-9a (C 103.8). The methylene proton 
resonances of the oxygenated prenyl, H-21 (H 4.13), showed HMBC correlations to the 
oxygenated aromatic carbon C-7 (C 139.1) and with C-8 (C 124.2) and C-8a (C 111.3). The 
methylene proton resonances for H-16 (H 3.60), of the other oxygenated prenyl unit, showed 
HMBC cross peaks with the resonances of the aromatic carbons C-5 (C 112.2), C-6 (C 
151.0) and C-10a (C 149.7). These data established the location of these oxygenated prenyl 
units at C-8 and C-5, respectively. The configuration of the oxygenated prenyl units at their 
alkene moieties were assigned as Z-17,18 and Z-22,23 on the basis of the NOESY correlations 
that were observed between H-16 (H 3.60) and H-20 (H 4.30); H-17 (H 5.40) and H-19 (H 
1.73); H-21 (H 4.13) and H-25 (H 4.26); and H-22 (H 5.59) and H-24 (H 1.73). Therefore, 
mckeanianone B was determined to be 1,6,7-trihydroxy-6,6-dimethyl-2H-pyrano(2,3:3,2)-
5,8-di(4-hydroxy-3-methylbut-2-enyl)-xanthone (2).  
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Table 1 
NMR spectroscopic data (400 MHz, CDCl3) for mckeanianones A-C (1-3)  
Position 
1  2  3 
H, (J in Hz) C (type) HMBC  H, (J in Hz) C (type) HMBC  H, (J in Hz) C (type) HMBC 
1 156.7 (C)    157.7 (C)    158.0 (C)  
2 104.7 (C)    104.3 (C)    104.5 (C)  
3 157.7 (C)    159.7 (C)    159.7 (C)  
4 106.9 (C)   6.25, s, 1H 94.1 (CH) 2, 3, 4a, 9, 9a   6.31, s, 1H 94.2 (CH) 2, 3, 4a, 9a 
4a 154.3 (C)    156.3 (C)    156.3 (C)  
5 152.5b (C)    112.2 (C)    112.2 (C)  
6 152.6b (C)    151.0 (C)    151.3 (C)  
7 141.8 (C)    139.1 (C)    139.4 (C)  
8 129.0 (C)    124.2 (C)    124.0 (C)  
8a 111.8 (C)    111.3 (C)    111.3 (C)  
9 183.5 (C)    182.8 (C)    182.9 (C)  
9a 104.1 (C)    103.8 (C)    103.9 (C)  
10a 153.6 (C)    149.7 (C)    150.0 (C)  
11 6.69, d (10.0), 1H 116.5 (CH) 2, 3, 13, 14  6.69, d (10.0), 1H 115.8 (CH) 1, 2, 3, 13, 14, 15  6.73, d (10.0), 1H 115.9 (CH) 1, 2, 3, 13 
12 5.69, d (10.0), 1H 128.0 (CH) 2, 13, 14  5.54, d (10.0), 1H 127.2 (CH) 2, 13, 14, 15  5.56, d (10.0), 1H 127.2 (CH) 2, 13, 14, 15 
13  78.5 (C)    78.0 (C)    78.0 (C)  
14 1.47, s, 3H 28.4 (CH3) 12, 13  1.44, s, 3H 28.4 (CH3) 12, 13, 15  1.47, s, 3H 28.5 (CH3) 12, 13, 15 
15 1.47, s, 3H 30.6 (CH3) 12, 13, 14  1.44, s, 3H 28.4 (CH3) 12, 13, 14  1.47, s, 3H 28.5 (CH3) 12, 13, 14 
16 3.42, d (6.8), 2H 21.9 (CH2) 3, 4, 4a, 17, 18  3.60, d (8.0), 2H 22.4 (CH2 ) 5, 6, 10a  3.67, d (7.4), 2H 22.4 (CH2) 5, 6, 10a, 17, 18 
17 5.21, brt (6.8), 1H 123.3 (CH) 4, 16  5.40, t (8.0), 1H 125.4 (CH) 19, 20  5.52, t (7.4), 1H 127.5 (CH) 19, 20 
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18  131.4 (C)    134.7 (C)    130.8 (C)  
19 1.63, s, 3H 25.9 (CH3) 17, 18, 20  1.73, s, 3H 22.6 (CH3) 17, 18, 20  1.73, s, 3H 21.5 (CH3) 17, 18, 20 
20 1.83, s, 3H 18.1 (CH3) 17, 18, 19  4.30, s, 2H 62.1 (CH2) 17, 18, 19  4.87, s, 2H 63.6 (CH2) 17, 18, 19, CO(Ac) 
21 4.17, d (6.2), 2H 26.3 (CH2) 7, 8, 8a, 22  4.13, d (7.8), 2H 26.1 (CH2) 7, 8, 8a, 22, 23  4.21, d (8.0), 2H 26.5 (CH2) 7, 8, 8a, 22, 23 
22 5.31, brt (6.2), 1H 124.4 (CH) 8, 21  5.59, t (7.8), 1H 127.5 (CH) 8, 24, 25  5.73, t (8.0), 1H 128.5 (CH) 24, 25 
23  131.5 (C)    133.7 (C)    132.9 (C)  
24 1.64, s, 3H 26.0 (CH3) 22, 23, 25  1.73, s, 3H 22.9 (CH3) 22, 23, 25  1.79, s, 3H 23.4 (CH3) 22, 23, 25 
25 1.86, s, 3H 18.3 (CH3) 22, 23, 24  4.26, s, 2H 62.3 (CH2) 22, 23, 24  4.37, s, 2H 63.2 (CH2) 22, 23, 24 
OH-1 13.97, s, 1H  1, 9a  13.78, brs, 1H    13.80, brs, 1H   
CO(Ac)          171.7 (C)  
CH3(Ac)         2.12, s, 3H 21.2 (CH3) CO(Ac) 
aMeasured in acetone-d6, 
bThese assignments could be interchanged. 
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Mckeanianone C (3) was obtained as a yellow viscous oil, that gave a [M+Na]+ ion at 
m/z 559.1945 in the HRESI-TOFMS which corresponded to the molecular formula C30H32O9 
(calcd for C30H32O9Na, m/z 559.1944). The UV, IR, 
1H and 13C NMR spectra indicated that 
compound 3 was closely related to compound 2, except the IR spectrum showed an additional 
band at 1736 cm-1, which indicated the presence of an ester carbonyl functional group. In 
conjunction with this, the 1H NMR spectrum also contained an additional resonance for an 
acetoxy group at H 2.12 (3H, s). The location of the acetoxy group at C-20 (C 63.6) was 
based on the HMBC correlation between the resonance for H2-20 (H 4.87) and that for the 
acetoxy carbonyl (C 171.7). This identified mckeanianone C as 1,6,7-trihydroxy-6,6-
dimethyl-2H-pyrano(2,3:3,2)-5-(4-acetoxy-3-methylbut-2-enyl)-8-(4-hydroxy-3-methylbut-
2-enyl)-xanthone (3). 
Mckeanianone D (4) was isolated as a yellow solid (mp 206-207 °C). The molecular 
formula C18H16O5 was indicated from the mass ion peak at m/z 312.09995 [M]
+ in its 
HREIMS spectrum. The UV, IR and NMR spectra were similar to those of compound 14,14 
except for the additional isoprene unit resonances [H 5.51 (1H, t, J = 6.6 Hz, H-12), 4.72 
(2H, d, J = 6.6 Hz, H-11), 1.80 (3H, s, H-15), 1.79 (3H, s, H-14)] in the 1H and 13C NMR 
spectra (Table 2). This isoprene unit was at C-3 (C 167.2) based on the HMBC correlations 
between H-11 (H 4.72) and the 13C NMR resonances for C-3, C-12 (C 120.0) and C-13 (C 
139.2). Therefore, mckeanianone D was determined to be 1,5-dihydroxy-3-O-(3-methylbut-2-
enyl)-xanthone (4) 
Mckeanianone E (5) was isolated as a yellow solid (decomposed >129 °C). Its 
HRESIMS displayed a positive molecular ion [M+H]+ at m/z 343.1179, which was consistent 
with the molecular formula of C19H18O6. The UV, IR and NMR spectra were similar to those 
of compound 13,13 with the only difference being an additional isoprene unit resonances [H 
5.30 (1H, t, J = 7.2 Hz, H-12), 3.37 (2H, d, J = 7.2 Hz, H-11), 1.80 (3H, s, H-15), 1.66 (3H, s, 
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H-14)] in the 1H and 13C NMR spectra (Table 2). This isoprene unit was at C-2 (C 110.4) on 
the basis of the HMBC correlations between H-11 (H 3.37) and the 13C NMR resonances for 
C-1 (C 161.2), C-2, C-12 (C 123.4) and C-13 (C 131.5). The structure of mckeanianone E 
was therefore confirmed to be 1,3,6-trihydroxy-7-methyoxy-2-(3-methylbut-2-enyl)-xanthone 
(5). This compound was synthesized earlier however its spectroscopic data was not 
reported.20 
Table 2  
NMR spectroscopic data (400 MHz in acetone-d6) of mckeanianones D (4) and E (5)  
Position 
4  5
H, (J in Hz) C (type) HMBC    H, (J in Hz) Ca (type) HMBC
a   
1  164.4 (C)    161.2 (C)  
2 6.35, d (2.2), 1H 98.4 (CH) 1, 3, 4, 9a   110.4 (C)  
3  167.2 (C)    163.2 (C)  
4 6.57, d (2.2), 1H 94.1 (CH) 2, 3, 4a, 9, 9a  6.49, s, 1H 93.9 (CH) 2, 3, 4a, 9, 9a 
4a  158.5 (C)    156.6 (C)  
5  147.0 (C)   6.92, s, 1H 103.5 (CH) 7, 8a, 9, 10a 
6 7.36, dd (7.9, 1.5), 1H 121.5 (CH) 8, 10a   155.0 (C)  
7 7.29, t (7.9), 1H 125.0 (CH) 5, 8a   146.6 (C)  
8 7.67, dd (7.9, 1.5), 1H 116.3 (CH) 6, 9, 10a  7.56, s, 1H 105.7 (CH) 6, 7, 9 
8a  122.5 (C)    113.1 (C)  
9  182.0 (C)    180.5 (C)  
9a  104.2 (C)    103.2 (C)  
10a  146.1 (C)    153.3 (C)  
11 4.72, d (6.6), 2H 66.4 (CH2) 3, 12, 13  3.37, d (7.2), 2H 22.0 (CH2) 1, 2, 12, 13 
12 5.51, t (6.6), 1H 120.0 (CH) 14, 15  5.30, t (7.2), 1H 123.4 (CH) 14, 15 
13  139.2 (C)    131.5 (C)  
14 1.79, s, 3H 25.8 (CH3) 12, 13, 15  1.66, s, 3H 25.9 (CH3) 12, 13, 15 
15 1.80, s, 3H 18.3 (CH3) 12, 13, 14  1.80, s, 3H 17.9 (CH3) 12, 13, 14 
OH-1 12.91, brs, 1H    13.45, brs, 1H  
OMe-7     3.99, s, 3H 56.6 (CH3) 7 
a Recorded at 500 MHz  
Mckeaniabiflavone (6) was obtained as a yellow solid (mp 237-239 °C). The molecular 
formula, C31H20O10, was deduced from the HRESI-TOFMS which show a pseudomolecular 
ion at m/z 553.1155 (calcd 553.1135) [M+H]+. The UV spectrum of compound 6 showed 
maximum absorption bands at max (MeOH) 218, 269 and 331 nm while the IR spectrum 
showed absorption bands for a hydroxy group and a conjugated carbonyl group at 3444 and 
1650 cm-1, respectively. The 1H NMR spectrum (Table 3) displayed resonances for two 
chelated hydroxy protons (H 13.09 and 12.97, each 1H, brs), two sets of four-aromatic 
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protons for two p-disubstituted aromatic rings [H 7.49 (2H, d, J = 8.4 Hz, H-2, H-6), 6.76 
(2H, d, J = 8.4 Hz, H-3, H-5); and 7.74 (2H, d, J = 8.4 Hz, H-2, H-6), 6.97 (2H, d, J = 
8.4 Hz, H-3, H-5)] which were assigned to the aromatic protons of rings B and E, 
respectively, four  uncoupled (singlet) aromatic protons (H 6.63, 6.57, 6.33 and 6.33, each 
1H, H-3, H-8, H-6 and H-6, respectively) and one methoxy group (H 3.82). The 13C NMR 
and DEPT 135 spectra of 6 displayed only twenty-seven resonances for the total of thirty-one 
carbons; eighteen quaternary carbons (C 183.3, 182.1, 165.2, 165.1, 164.7, 163.6, 163.5, 
163.1, 163.0, 160.8, 158.9, 156.4, 124.8, 124.2, 111.2, 105.6, 104.7 and 100.5), twelve 
methine carbons [C 130.9 (2C), 128.8 (2C), 116.1 (2C), 115.4 (2C), 104.5, 99.9, 99.8 and 
94.7] and one methyl (C 55.9) carbon. The chelated hydroxy proton at H 12.97 showed 
HMBC correlations to C-5 (C 163.1), C-6 (C 99.8) and C-10 (C 104.7). The aromatic 
proton resonating at H 6.33 was assigned to H-6 due to its HMQC cross peak with C-6 as 
well as the HMBC correlations with C-7 (C 165.2) and C-8 (C 94.7). The aromatic proton 
H-6 correlated with H-8 (H 6.57) in the 1H-1H COSY spectrum which correlated with C-4 
(C 182.1), C-6, C-7, C-9 (C 158.9) and C-10 in the HMBC spectrum. The HMBC 
correlations between the aromatic protons H-2 (H 7.49, of the p-disubstituted aromatic ring) 
and C-2 (C 165.1) established the attachment of this aromatic unit at C-2. The substituent at 
C-4 (C 160.8) of the p-disubstituted aromatic ring was assigned as a hydroxy group on the 
basis of its chemical shift. Consequently this data together with the chemical shifts of C-3 (C 
111.2), C-5 and C-7 suggested a 3-substitued-5,7-dihydroxy-(4-hydroxyphenyl) flavone 
moiety. In the other flavone unit, the chelated hydroxy proton (H 13.09) was located at C-5 
(C 163.0) due to its HMBC correlations to C-5, C-6 (C 99.9) and C-10 (C 105.6). The 
olefinic proton at H 6.63 (H-3) showed cross peaks in the HMBC spectrum to C-2 (C 
164.7), C-4 (C 183.3), C-10 and C-1 (C 124.2) of the p-disubstituted aromatic ring. In 
addition, C-4 of this aromatic ring was substituted by a hydroxy group due to its low field 
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chemical shift (C 163.6). The aromatic proton resonating at H 6.33 was located at C-6 from 
the HMQC spectrum as well as the HMBC correlations between H-6 and C-3, C-4, C-5, 
C-7 (C 163.5), C-8 (C 100.5) and C-10. The HMBC correlations between H-6 and C-3 
indicated that the two flavone units were linked between C-3 and C-8. This was further 
supported by a comparison of the NMR spectroscopic data of 6 with those of the related 
biflavones, biapigenin (the de-O-methyl derivative of 6)21 and its constitutional isomer, 4'''-
O-methyl-biapigenin.22 These three compounds had very similar 1H and 13C NMR 
spectroscopic data, except for the resonances associated with the presence or absence of the 
methoxy group. Thus compound mckeaniabiflavone was identified as 7-methoxy-
4,4,5,5,7-pentahydroxy-[38]-biflavone (6).  
Table 3 
NMR spectroscopic data (400 MHz, acetone-d6) for mckeaniabiflavone (6) 
                                                                                             6  
Position H, (J in Hz) C (type) HMBC Position H, (J in Hz) C (type) HMBC 
2  165.1 (C)  2  164.7 (C)  
3  111.2 (C)  3 6.63, s, 1H 104.5 (CH) 2, 4, 10, 1 
4  182.1 (C)  4  183.3 (C)  
5  163.1 (C)  5  163.0 (C)  
6 6.33, brs, 1H 99.8 (CH) 7, 8 6 6.33, brs, 1H 99.9 (CH) 3, 4, 5, 7, 8, 10
7  165.2 (C)  7  163.5 (C)  
8 6.57, s, 1H 94.7 (CH) 4, 6, 7, 9, 10 8  100.5 (C)  
9  158.9 (C)  9  156.4 (C)  
10  104.7 (C)  10  105.6 (C)  
1  124.8 (C)  1  124.2 (C)  
2 7.49, d (8.4), 1H 130.9 (CH) 2, 3, 4 2 7.74, d (8.4), 1H 128.8 (CH) 3, 4 
3 6.76, d (8.4), 1H 116.1 (CH) 2, 1, 2, 4 3 6.97, d (8.4), 1H 115.4 (CH) 1, 4 
4  160.8 (C)  4  163.6 (C)  
5 6.76, d (8.4), 1H 116.1 (CH) 2, 1, 2, 4 5 6.97, d (8.4), 1H 115.4 (CH) 1, 4 
6 7.49, d (8.4), 1H 130.9 (CH) 2, 3, 4 6 7.74, d (8.4), 1H 128.8 (CH) 4, 5  
OH-5 12.97, brs, 1H  5, 6, 10 OH-5 13.09, brs, 1H  5, 6, 10 
   OMe-7 3.82, s, 3H 55.9 (CH3) 7 
 
All of the isolated compounds were tested for their antimalarial activities against the 
Plasmodium falciparum strains, TM4 and K1 (a multidrug resistant strain)23 and their 
cytotoxic activity against a Vero cell line (African green monkey kidney cells)24 (Table 4). 
The five pyrano-xanthones 1-3, 7 and 8, all isolated from the leaves and having two isoprene 
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substituents, were generally the most active compounds and showed significant activities 
against the TM4 and K1 strains with IC50 values in the range of 6.0±1.1 
_ 8.5±1.2 and 3.6±1.7 
_ 7.3±1.2 µM, respectively. Only compounds, 1 and 7, were not tested against Vero cells 
(Table 4).  
Table 4 
Antimalarial and cytotoxic activities (IC50, µM) 
Compoundsa 
Antimalarial activity against P. falciparum Cytotoxic activity 
TM4 K1  Vero cells 
1 6.20.4 5.20.4  -b 
2 6.70.6 6.40.5  12.60. 9 
3 6.01.1 6.60.7  29.53.9 
4 15.1.03.9 14.31.8  -c 
5 27.73.4 25.72.3  -c 
7 8.51.2 3.61.7  -b 
8 8.30.9 7.31.2  13.24.6 
10 13.74.5 19.82.0  36.58.0 
11 22.10.7 19.51.0  -c 
17 10.80.7 15.42.6  25.31.4 
18 39.16.3 32.75.99  31.32.6 
19 31.52.0 25.12.1  -c 
Ellipticined    0.4 
Chloroquinee 0.03 0.30.04   
Cycloguanile 0.040.01 3.20.8   
Pyrimethaminee 0.080.01 31.08.4   
a Compounds 6, 9 and 12-16 were inactive in all assays. b Due to insolubility problems an accurate value could 
not be obtained. c Inactive at IC50  50 µM. d Positive control for cytotoxic assay. e Reference drugs for 
antiplasmodial activity.  
 
Compounds 2, 3 and 8 were 2-5 times less cytotoxic against Vero cells (IC50 values of 
12.6±0.9, 29.5±3.9 and 13.2±4.6 µM, respectively) in comparison with their antiplasmodial 
activities. The xanthones, 4, 5, 10, 11 and 17-19, having one free or cyclized isoprene 
substituent had significantly weaker antiplasmodial activities and cytotoxicities. The 
xanthones 12 and 16, the xanthones (13-15), having no isoprene substituent, and the 
biflavones, 6 and 9 were inactive in all assays. Other Garcinia species containing xanthones 
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have been documented to have antiplasmodial activities.25a-c Some of these xanthones have 
the 9-xanthone structure related to compounds 4, 5, 10, 11 and 17-19 while three others 
(isolated from the stem bark of G. vieillardii, demethylcalabaxanthone, dombakina-xanthone 
and macluraxanthone) have the pyrano-xanthone stucture found in compounds 1-3, 7 and 8 
that were isolated here, but having one or two isoprene subsituents. These three compounds 
had antiplasmodial activities with IC50 values in the range of 0.9-1.9 µg/mL, however their 
cytotoxic activities were not reported.25c 
3. Conclusions 
Six new natural products and twelve known compounds was the first report that 
isolated from G. mckeaniana. The isolated compounds showed antimalarial activities against 
the Plasmodium falciparum strains, TM4 and K1, and cytotoxic activities against a Vero cell 
line. The isolated xanthone compounds, having a pyrano ring and two isoprene units, showed 
the highest antimalarial activities against the P. falciparum strains, and cytotoxic activities 
against a Vero cell line than those with only one isoprene unit. While the xanthones and 
biflavanoids, without an isoprene unit, were inactive in all assays.  
4. Spectral data of new compounds 
4.1 Mckeanianone A (1) 
Yellow solid; mp 187-189 °C; Rf (20% acetone/hexanes) 0.29; UV (MeOH) max (log ) 
217 (4.39), 295 (4.61), 337 (4.04), 384 (3.79) nm; IR (neat) max 3418, 1649, 1610, 1463 cm-
1; H (400 MHz, acetone-d6) 13.97 (1 H, s, OH-1), 6.69 (1 H, d, J 10.0 Hz, H-11), 5.69 (1 H, 
d, J 10.0 Hz, H-12), 5.31 (1 H, br t, J 6.2 Hz, H-22), 5.21 (1 H, br t, J 6.8 Hz, H-17), 4.17 (2 
H, d, J 6.2 Hz, H-21), 3.42 (2 H, d, J 6.8 Hz, H-16), 1.86 (3 H, s, H-25), 1.83 (3 H, s, H-20), 
1.64 (3 H, s, H-24), 1.63 (3 H, s, H-19), 1.47 (6 H, s, H-14 and H-15); C (100 MHz, acetone-
d6) 183.5, 157.7, 156.7, 154.3, 153.6, 152.6, 152.5, 141.8, 131.5, 131.4, 129.0, 128.0, 124.4, 
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123.3, 116.5, 111.8, 106.9, 104.7, 104.1, 78.5, 30.6, 28.4, 26.3, 26.0, 25.9, 21.9, 18.3, 18.1; 
HRESI-TOFMS: m/z 479.2063 [M+H]+, calcd for 479.2070, C28H31O7. 
4.2 Mckeanianone B (2)  
Yellow viscous oil; Rf (30% acetone/hexanes) 0.30; UV (MeOH) max (log ) 218 (4.49), 
292 (4.57), 338 (4.18), 379 (3.96) nm; IR (neat) max 3447, 1650, 1611, 1446, 1288 cm-1; H 
(400 MHz, CDCl3) 13.78 (1 H, s, OH-1), 6.69 (1 H, d, J 10.0 Hz, H-11), 6.25 (1 H, s, H-4), 
5.59 (1 H, t, J 7.8 Hz, H-22), 5.54 (1 H, d, J 10.0 Hz, H-12), 5.40 (1 H, t, J 8.0 Hz, H-17), 
4.30 (2 H, s, H-20), 4.26 (2 H, s, H-25), 4.13 (2 H, d, J 7.8 Hz, H-21), 3.60 (2 H, d, J 8.0 Hz, 
H-16), 1.73 (6 H, s, H-19 and H-24), 1.44 (6 H, s, H-14 and H-15); C (100 MHz, CDCl3) 
182.8, 159.7, 157.7, 156.3, 151.0, 149.7, 139.1, 134.7, 133.7, 127.5, 127.2, 125.4, 124.2, 
115.8, 112.2, 111.3, 104.3, 103.8, 94.1, 78.0, 62.3, 62.1, 28.4 (2C), 26.1, 22.9, 22.6, 22.4; 
HRESI-TOFMS: m/z 517.1839 [M+Na]+, calcd for 517.1838, C28H30O8Na.  
4.3 Mckeanianone C (3)  
Yellow viscous oil; Rf (20% acetone/hexanes) 0.31; UV (MeOH) max (log ) 217 (4.62), 
292 (4.70), 338 (4.09), 382 (4.04) nm; IR (neat) max 3418, 1736, 1650, 1597, 1448, 1244 cm-
1; H (400 MHz, CDCl3) 13.80 (1 H, br s, OH-1), 6.73 (1 H, d, J 10.0 Hz, H-11), 6.31 (1 H, s, 
H-4), 5.73 (1 H, t, J 8.0 Hz, H-22), 5.56 (1 H, d, J 10.0 Hz, H-12), 5.52 (1 H, t, J 7.4 Hz, H-
17), 4.87 (2 H, s, H-20), 4.37 (2 H, s, H-25), 4.21 (2 H, d, J 8.0 Hz, H-21), 3.67 (2 H, d, J 7.4 
Hz, H-16), 2.12 (3 H, s, CH3(Ac)), 1.79 (3 H, s, H-24), 1.73 (3 H, s, H-19), 1.47 (6 H, s, H-14 
and H-15); C (100 MHz, CDCl3) 182.9, 171.7, 159.7, 158.0, 156.3, 151.3, 150.0, 139.4, 
132.9, 130.8, 128.5, 127.5, 127.2, 124.0, 115.9, 112.2, 111.3, 104.5, 103.9, 94.2, 78.0, 63.6, 
63.2, 28.5 (2C), 26.5, 23.4, 22.4, 21.5, 21.2; HRESI-TOFMS: m/z 559.1945 [M+Na]+, calcd 
for 559.1944, C30H32O9Na. 
4.4 Mckeanianone D (4) 
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Yellow solid; mp 206-207 °C; Rf (20% EtOAc/hexanes) 0.35; UV (MeOH) max (log ) 
252 (4.20), 312 (3.85), 369 (3.18) nm; IR (neat) max 3385, 1653, 1569, 1456 cm-1; H (400 
MHz, acetone-d6) 12.97 (1 H, br s, OH-1), 7.67 (1 H, dd, J 7.9, 1.5 Hz, H-8), 7.36 (1 H, dd, J 
7.9, 1.5 Hz, H-6), 7.29 (1 H, t, J 7.9 Hz, H-7), 6.57 (1 H, d, J 2.2 Hz, H-4), 6.35 (1 H, d, J 2.2 
Hz, H-2), 5.51 (1 H, t, J 6.6 Hz, H-12), 4.72 (2 H, d, J 6.6 Hz, H-11), 1.80 (3 H, s, H-15), 
1.79 (3 H, s, H-14); C (100 MHz, acetone-d6) 182.0, 167.2, 164.4, 158.5, 147.0, 146.1, 
139.2, 125.0, 122.5, 121.5, 120.0, 116.3, 104.2, 98.4, 94.1, 66.4, 25.8, 18.3; HRMS (EI): m/z 
312.09995 [M]+ (calcd for 312.09977, C18H16O5). 
4.5 Mckeanianone E (5) 
Yellow solid; mp decomposed >129 °C; Rf (30% EtOAc/hexanes) 0.28; UV (MeOH) 
max (log ) 258 (4.41), 320 (4.18), 366 (3.98) nm; IR (neat) max 3269, 1647, 1559, 1482 cm-
1; H (400 MHz, acetone-d6) 13.45 (1 H, br s, OH-1), 7.56 (1 H, s, H-8), 6.92 (1 H, s, H-5), 
6.49 (1 H, s, H-4), 5.30 (1 H, t, J 7.2 Hz, H-12), 3.99 (3 H, s, OMe-7), 3.37 (2 H, d, J 7.2 Hz, 
H-11), 1.80 (3 H, s, H-15), 1.66 (3 H, s, H-14); C (125 MHz, acetone-d6) 180.5, 163.2, 
161.2, 156.6, 155.0, 153.3, 146.6, 131.5, 123.4, 113.1, 110.4, 105.7, 103.5, 103.2, 93.9, 56.6, 
25.9, 22.0, 17.9; HRESI-TOFMS: m/z 343.1179 [M+H]+ (calcd for 343.1182, C19H19O6). 
4.6 Mckeaniabiflavone (6) 
Yellow solid; mp 237-239 °C; Rf (5% MeOH/CH2Cl2) 0.45; UV (MeOH) max (log ) 
218 (4.57), 269 (4.51), 331 (4.30) nm; IR (neat) max 3444, 1650, 1608, 1508, 1178 cm-1; H 
(400 MHz, acetone-d6) 13.09 (1 H, br s, OH-5), 12.97 (1 H, br s, OH-5), 7.74 (2 H, d, J 8.4 
Hz, H- 2 and H-6), 7.49 (2 H, d, J 8.4 Hz, H-2 and H-6), 6.97 (2 H, d, J 8.4 Hz, H-3 
and H-5), 6.76 (2 H, d, J 8.4 Hz, H-3 and H-5), 6.63 (1 H, s, H-3), 6.57 (1H, s, H-8), 6.33 
(2 H, br s, H-6 and H-6), 3.82 (3 H, s, OMe-7); C (100 MHz, acetone-d6) 183.3, 182.1, 
165.2, 165.1, 164.7, 163.6, 163.5, 163.1, 163.0, 160.8, 158.9, 156.4, 130.9 (2C), 128.8 (2C), 
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124.8, 124.2, 116.1 (2C), 115.4 (2C), 111.2, 105.6, 104.7, 104.5, 100.5, 99.9, 99.8, 94.7, 
55.9; HRESI-TOFMS: m/z 553.1155 [M+H]+, calcd for 553.1135, C31H21O10. 
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